Policy Statement Concerning the Suppression of Accuracy in Artificial Intelligence Systems
FTC proposes policy statement that suppressing accuracy in AI systems may be a deceptive act or practice under Section 5 of the FTC Act, with potential enforcement actions including civil penalties and injunctions.
Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on July 29, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Health systems, medical device companies, health tech startups, and digital health compliance teams developing or deploying AI systems that could suppress accuracy (e.g., by omitting or downplaying known limitations or biases). should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified; the policy statement is proposed and subject to public comment. Companies should act proactively before finalization.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The FTC is signaling that it will treat the suppression of accuracy in AI systems as a deceptive practice, expanding enforcement risk for companies that fail to disclose material limitations or biases in their AI products.
Who it affects
Health systems, medical device companies, health tech startups, and digital health compliance teams developing or deploying AI systems that could suppress accuracy (e.g., by omitting or downplaying known limitations or biases).
What you must do
Review AI systems for any practices that suppress accuracy (e.g., omitting known error rates, biases, or limitations) and ensure transparent disclosure to users and regulators.
Deadline
Not specified; the policy statement is proposed and subject to public comment. Companies should act proactively before finalization.
Never miss a change like this again
Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Healthcare AI Regulation (FDA / ONC)
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Diabetes Digital Behavioral Therapeutic Device
- HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information
- Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions To Unleash Prosperity
- Nondiscrimination in Health Programs and Activities
- Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing